Medicare Advantage Enrollment and Access to Kidney Transplant After the 21st Century Cures Act
In the authors' words
This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.
Main result
Conclusions and Relevance: In the first 3 years following the 21st Century Cures Act, Medicare Advantage beneficiaries with ESKD had substantially lower transplant and wait-listing rates than traditional Medicare beneficiaries.
Appeared: Wednesday, September 23. JAMA. Peer-reviewed journal.